Get started
Author

Johan Holst

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
2009 · Johan Holst, Diana Martin, et al. · Vaccine · 405
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
2013 · Johan Holst, Philipp Oster, et al. · Human Vaccines & Immunotherapeutics · 225
PDF
Intranasal Administration of a Meningococcal Outer Membrane Vesicle Vaccine Induces Persistent Local Mucosal Antibodies and Serum Antibodies with Strong Bactericidal Activity in Humans
1998 · Bjørn Haneberg, Rolf Dalseg, et al. · Infection and Immunity · 134
PDF
The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease
2011 · Lee H. Harrison, Stephen I. Pelton, et al. · Vaccine · 132
The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease
2005 · J HOLST, B FEIRING, et al. · Vaccine · 104
Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease
2003 · Carl E. Frasch, Loek van Alphen, et al. · Humana Press eBooks · 81
Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice
1999 · Rolf Dalseg, Elisabeth Wedege, et al. · Vaccine · 52
Developing vaccines against epidemic-prone emerging infectious diseases
2019 · Valentina Bernasconi, Paul A. Kristiansen, et al. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 47
PDF
Strategies for Development of Universal Vaccines Against Meningococcal Serogroup B Disease
2007 · Johan Holst · Human Vaccines · 45
PDF
Antigen-Specific T-Cell Responses in Humans after Intranasal Immunization with a Meningococcal Serogroup B Outer Membrane Vesicle Vaccine
1999 · Fredrik Oftung, Lisbeth Meyer Næss, et al. · Infection and Immunity · 43
Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine
2000 · Aud Katrine Herland Berstad, Svein Rune Andersen, et al. · Vaccine · 41
A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin
1997 · Aud Katrine Herland Berstad, Johan Holst, et al. · Vaccine · 34
Outer Membrane Vesicles From Neisseria Meningitidis: Effects on Cytokine Production in Human Whole Blood
2001 · Mohammad Reza Mirlashari, Ernst Arne Høiby, et al. · Cytokine · 32
Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks
2006 · Muhamed-Kheir Taha, Maria Leticia Zarantonelli, et al. · Vaccine · 31
Meningococcal Outer Membrane Vesicle Vaccine Given Intranasally Can Induce Immunological Memory and Booster Responses without Evidence of Tolerance
2001 · Hilde Bakke, Kristian Lie, et al. · Infection and Immunity · 30
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
2020 · Megan L. Heinrich, Matthew L. Boisen, et al. · Scientific Reports · 29
PDF
Outer Membrane Vesicles from Neisseria meningitidis: Effects on Tissue Factor and Plasminogen Activator Inhibitor-2 Production in Human Monocytes
2001 · Mohammad Reza Mirlashari, Ernst Arne Høiby, et al. · Thrombosis Research · 28
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys
2000 · Eileene Rouppe van der Voort, Margje Schuller, et al. · Vaccine · 23
A Non-Living Nasal Influenza Vaccine Can Induce Major Humoral and Cellular Immune Responses in Humans without the Need for Adjuvants
2005 · Helvi Holm Samdal, Hilde Bakke, et al. · Human Vaccines · 22
PDF
Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease
1999 · Marc Fischer, George M. Carlone, et al. · Vaccine · 21
Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccines
2003 · Anita Haugan, Phuong Xuan Thi Dao, et al. · Vaccine · 20
Can nonliving nasal vaccines be made to work?
2002 · Bjørn Haneberg, Johan Holst · Expert Review of Vaccines · 18
Bacteria-derived particles as adjuvants for non-replicating nasal vaccines
2001 · Bjørn Haneberg, Aud Katrine Herland Berstad, et al. · Advanced Drug Delivery Reviews · 18
Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway
2014 · Johan Holst, Maurizio Comanducci, et al. · Vaccine · 10
Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory
2003 · Hilde Bakke, Torhild N. Setek, et al. · Vaccine · 10
Works count: 39
Citation count: 1,667
H-index: 20
I10-index: 25
Year
Topic
Type